Thus, the disease entity of LOHF in Japan differed from that in Europe and the United States [14], because patients with no histological evidence of hepatitis and/or prothrombin time values of >40 % of the standardized value were excluded from the diagnosis of LOHF in Japan, even if they had grade II or more severe hepatic encephalopathy. The gene discussed is F2; the disease is Hepatitis.